Concepedia

M. de Locht

MD

Statistics

Publications

5

Citations

716

H-Index

5

Active since

1993

Affiliations

AZ Sint-Jan(Current)

UCLouvain

Janssen (Belgium)

M. de Locht is an author at AZ Sint-Jan specializing in pharmacology, life sciences, and microbiology.

Publications per year

1993–1994

5

Publications

5

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Johan R. Boelaert, M. de Locht, J. Van Cutsem et al. · Journal of Clinical Investigation · 1993 · 343 citations · Full text

, , +17

Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect

Johan R. Boelaert, J. Van Cutsem, M. de Locht et al. · Kidney International · 1994 · 167 citations · Full text

, , +7

Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of rhizopus microsporus

M. de Locht, Johan R. Boelaert, Yves‐Jacques Schneider · Biochemical Pharmacology · 1994 · 123 citations

, , +8

Side-effects of desferrioxamine in dialysis patients

Johan R. Boelaert, M. de Locht · Nephrology Dialysis Transplantation · 1993 · 69 citations

, , +16

Desferrioxamine

Johan R. Boelaert, M. de Locht, J. Van Cutsem · Reviews in Medical Microbiology · 1993 · 14 citations

, , +12

1–5 of 5